Larvol Delta - Clarametyx-Biosciences-Announces-Progress-on-Study-of-Antibody-Therapy-CMTX101-for-Infections-Associated-With-Cystic-Fibrosis

CMTX-101 - Clarametyx Biosci

https://www.businesswire.com/news/home/20241015655882/en/Clarametyx-Biosciences-Announces-Progress-on-Study-of-Antibody-Therapy-CMTX-101-for-Infections-Associated-With-Cystic-Fibrosis

Oct 17, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next